Magnetic Nanoparticles in Precision Cancer Therapy: From Synthesis and Biological Interactions to Clinical Translation
International Journal of Molecular Sciences · 06.11.2026 · 27 (21) · 9938
DOI: 10.3390/ijms27219938 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 06.11.2026. Verfasst von Jing Wang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Erasmus University Medical Center, 3015 GD Rotterdam, The Netherlands. Hauptthemen laut MEDLINE: Neoplasms, Magnetite Nanoparticles, Precision Medicine. Die Arbeit nennt 280 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: China Scholarship Council.
Abstract (Originalsprache)
Cancer treatment increasingly relies on integrated therapeutic approaches, particularly for solid tumors that remain difficult to eradicate using a single modality. Magnetic nanoparticles (MNPs) have emerged as versatile therapeutic platforms owing to their magnetic responsiveness and tunable physicochemical properties. Advances in synthesis methods enable precise control over MNP size, morphology, composition, and surface chemistry, shaping their biological behavior across multiple scales. At the cellular level, these properties regulate nanoparticle uptake, intracellular trafficking, and subcellular interactions. At the tissue and systemic levels, administration route, vascular transport, magnetic targeting, and ligand-mediated recognition influence biodistribution, tumor accumulation, and cellular selectivity. Material composition and surface functionalization further determine responsiveness to external or endogenous stimuli and mediate therapeutic effects, including heat generation, controlled drug release, catalytic activity, and reactive oxygen species production. These features allow MNP-based systems to support localized hyperthermia, drug delivery, catalytic therapies, and embolization-based interventions, making them attractive for treating deep-seated and inoperable tumors. However, heterogeneous tumor delivery, variable activation efficiency, off-target toxicity, and long-term safety concerns remain major barriers to clinical translation. Overall, this review summarizes recent advances and current limitations in MNP-based cancer therapy, providing a multiscale perspective that links material design, biological interactions, systemic delivery, therapeutic activation, and translational challenges.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology, Erasmus University Medical Center, 3015 GD Rotterdam, The Netherlands.
- Institute of Frontier Medical Sciences, Jilin University, Changchun 130021, China.
- Department of Clinical Genetics, Erasmus University Medical Center, Sophia Children's Hospital, 3015 GD Rotterdam, The Netherlands.
- State Key Laboratory for Diagnosis and Treatment of Severe Zoonotic Infectious Diseases, Key Laboratory for Zoonosis Research of the Ministry of Education, Institute of Zoonosis, College of Veterinary Medicine, Jilin Un…
ORCID-Profile: Jing Wang, Wei Zhang, Andrea Sacchetti
Förderung
- China Scholarship Council
Zitieren
APA
Wang, J., Xu, S., Hosseinikhah, S. M., Zhang, W., Zhang, X., & Sacchetti, A. (2026). Magnetic Nanoparticles in Precision Cancer Therapy: From Synthesis and Biological Interactions to Clinical Translation. International Journal of Molecular Sciences, 27(21), 9938. https://doi.org/10.3390/ijms27219938
Vancouver
Wang J, Xu S, Hosseinikhah SM, Zhang W, Zhang X, Sacchetti A. Magnetic Nanoparticles in Precision Cancer Therapy: From Synthesis and Biological Interactions to Clinical Translation. International Journal of Molecular Sciences. 2026;27(21):9938. doi:10.3390/ijms27219938
BibTeX
@article{Wang2026,
author = {Wang, Jing and Xu, Shizhi and Hosseinikhah, Seyedeh Maryam and Zhang, Wei and Zhang, Xiao and Sacchetti, Andrea},
title = {Magnetic Nanoparticles in Precision Cancer Therapy: From Synthesis and Biological Interactions to Clinical Translation},
journal = {International Journal of Molecular Sciences},
year = {2026},
volume = {27},
number = {21},
pages = {9938},
doi = {10.3390/ijms27219938}
}
EUVIMED